Skip to content

Analysis of Influencing Factors on the Therapeutic Effect of Stellate Ganglion Block in Patients with Insomnia Disorder

Analysis of Influencing Factors on the Therapeutic Effect of Stellate Ganglion Block in Patients with Insomnia Disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112461
Enrollment
Unknown
Registered
2025-11-14
Start date
2025-11-14
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia disorder

Interventions

Observation group:None

Sponsors

The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Age: 18-65 years old, gender not limited; 2.It meets the diagnostic criteria for insomnia as stipulated in the "Chinese Guidelines for the Diagnosis and Treatment of Insomnia in Adults (2017 Edition)", that is, it has one or more of the following symptoms: difficulty falling asleep (sleep latency > 30 minutes), sleep maintenance disorder (>=2 awakenings throughout the night), early awakening, decreased sleep quality and reduced total sleep time (usually less than 6.5 hours), and these symptoms occur at least three times a week. It lasts for more than three months.

Exclusion criteria

Exclusion criteria: 1.Combined with severe cardiovascular or cerebrovascular diseases, liver or kidney dysfunction, endocrine disorders or other major systemic diseases; 2.Known to be allergic to lidocaine or other local anesthetics; 3.Abnormal coagulation function or infection at the puncture site; 4.Consciousness or cognitive impairment; 5.Diagnose other types of sleep disorders, such as sleep-related breathing disorders, hypersomnia, parasomnia, restless legs syndrome, and circadian rhythm sleep-wake disorders; 6.Meets the diagnostic criteria for alcohol use disorder or substance use disorder involving the abuse of opioids, stimulants, marijuana and prescription drugs; 7.Four weeks before the treatment, in addition to the prescribed hypnotic drugs, drugs known to significantly affect sleep structure were used.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Scale (PSQI) Score;

Secondary

MeasureTime frame
Patient Health Questionnaire -9 (PHQ-9);Heart Rate variability Test (HRV);Generalized Anxiety Disorder Scale-7 (GAD-7)Score;

Countries

China

Contacts

Public ContactZhang Xinjian

The Third Affiliated Hospital of Guangzhou University of Chinese Medicine

mzkzxj@163.com+86 13265117786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026